These data suggested unlikely adverse contribution of cre transgene or microbiome impact in this system at baseline and invoked the possibility that exogenous changes in adipocyte size/function (e.g., obesity) might be required to uncover the role of PKM2 in adipocytes. The gene discussed is PKM; the disease is obesity disorder.